Here’s what is actually very hot — and what is not — in fintech correct now

Here’s what is actually very hot — and what is not — in fintech correct now


Crucial Factors
  • At Dollars 20/20 in Amsterdam this week, organization-going through fintechs like Airwallex, Payoneer, and ClearBank had been all the rage, whilst client apps these kinds of as Revolut have been nowhere to be identified.
  • The region that drew the most buzz from Revenue 20/20 attendees was artificial intelligence, with fintech and banking leaders wanting to harness the technology’s opportunity while evaluating the hazards.
  • Quite a few fintech executives CNBC interviewed spoke of how they’re not intrigued in launching goods customized to crypto as the demand from their prospects is just not there.



Supply

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]

Read More
Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’
Finance

Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’

Key Points Raymond James estimates that what consumers pay in higher gas prices could total exactly what they’re set to gain with the tax changes under President Donald Trump’s “big beautiful bill.” The stimulus was expected to boost both the U.S. economy and markets in 2026.  While consumers may not get as much of a […]

Read More
Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more
Finance

Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more

Check out the companies making headlines before the bell: Kohl’s — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.07 per share exceeded the expected 85 cents per share. Casey’s General Stores — The convenience […]

Read More